<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651676</article-id><article-id pub-id-type="doi">10.31857/S0869813924020082</article-id><article-id pub-id-type="edn">DJAGXG</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Effect of dietary phospholipid on the behavior in C57BL/6J mice</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние приема фосфолипидов на формирование поведенческих характеристик у лабораторных мышей C57BL/6J</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Boldyreva</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Болдырева</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kozhevnikovaen@neuronm.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Morozova</surname><given-names>М. V.</given-names></name><name xml:lang="ru"><surname>Морозова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kozhevnikovaen@neuronm.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlov</surname><given-names>К. S.</given-names></name><name xml:lang="ru"><surname>Павлов</surname><given-names>К. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kozhevnikovaen@neuronm.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kozhevnikova</surname><given-names>Е. N.</given-names></name><name xml:lang="ru"><surname>Кожевникова</surname><given-names>Е. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kozhevnikovaen@neuronm.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Scientific Research Institute of Neurosciences and Medicine</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт нейронаук и медицины</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2024</year></pub-date><volume>110</volume><issue>2</issue><issue-title xml:lang="ru"/><fpage>254</fpage><lpage>267</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/651676">https://journals.eco-vector.com/0869-8139/article/view/651676</self-uri><abstract xml:lang="en"><p>Nowadays phospholipids are widely used as hepatoprotective, neuroprotective and anti-stress drugs, as well as the dietary supplements. Besides, lecithin consisting up to 70% of the phospholipids mixture: phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phosphatidic acid, is the often component of food production as an emulsifier. Dose of these biologically active substances in the modern human diet could be quite high. Previously we have shown that chronic intestinal inflammation in <italic>Muc2</italic>-knockout mice induces behavioral changes along with the significant increase in the content of phospholipids in intestinal epithelial cells, particularly, phosphatidylcholine, phosphatidylserine and phosphatidic acid. Here we investigate the effects of long-term administration of a mixture of these phospholipids, as well as the effects of long-term administration of soy lecithin on the behavioral patterns in laboratory mice. Animals long-term taken a phospholipid mixture shows no normally observed preference towards females in the two intruders test (with female and male). In the social odor preference test, they also did not distinguish female and male odors, while non-social odors discrimination preserved. In addition, we identified a decrease in anxiety, obsessive traits, and schizophrenia-like behavior traits in these animals. Soy lecithin supplementation had similar effects on social behavior and compulsive traits, and increased aggression in males. Thus, long-term perinatal administration of either mixture of phospholipids (phosphatidylcholine, phosphatidylserine and phosphatidic acid) or soy lecithin can influence various aspects of behavior in mice.</p></abstract><trans-abstract xml:lang="ru"><p>Препараты на основе фосфолипидов широко используются в качестве гепатопротекторных, нейропротекторных и антистрессовых лекарств, а также в составе биологически активных добавок. Кроме этого, лецитин, содержащий в своем составе до 70% смеси фосфолипидов – фосфатидилхолина, фосфатидилэтаноламина, фосфатидилинозитола и фосфатидной кислоты, повсеместно применяется в пищевом производстве в качестве эмульгатора. Дозы этих биологически активных веществ в диете современного человека могут быть очень высоки. Ранее мы показали, что хроническое воспаление кишки у мышей с мутацией в гене <italic>Muc2</italic> приводит к нарушению поведения одновременно с существенным повышением содержания ряда форм фосфолипидов в клетках эпителия кишечника: фосфатидилхолина, фосфатидилсерина и фосфатидной кислоты. В данной работе мы исследовали эффекты длительного приема смеси этих фосфолипидов, а также эффекты длительного приема соевого лецитина на формирование поведенческих паттернов у мышей. Животные, длительно принимавшие смесь фосфолипидов, не демонстрировали естественного предпочтения по отношению к самке в тесте с двумя интрудерами (самкой и самцом). В тесте на социальные запахи они также не различали запахи самки и самца, в то время как дискриминация несоциальных запахов сохранилась. Кроме того, мы выявили снижение признаков компульсивности и тревожности при этом и отдельные черты шизофреноподобного поведения у таких животных. Прием соевого лецитина оказал схожее влияние на социальное поведение и компульсивные черты и вызвал повышение агрессии у самцов. Таким образом, долговременный перинатальный прием как смеси фосфолипидов (фосфатидилхолина, фосфатидилсерина и фосфатидной кислоты), так и соевого лецитина способен оказывать влияние на различные аспекты поведения у мышей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>behavior</kwd><kwd>phosphatidylcholine</kwd><kwd>phosphatidylserine</kwd><kwd>phosphatidic acid</kwd><kwd>soy lecithin</kwd><kwd>C57BL/6J laboratory mice</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>поведение</kwd><kwd>фосфатидилхолин</kwd><kwd>фосфатидилсерин</kwd><kwd>фосфатидная кислота</kwd><kwd>соевый лецитин</kwd><kwd>лабораторная мышь C57BL/6J</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>№ 23-25-00417</award-id></award-group><funding-statement xml:lang="en">This work was funded by the Russian Science Foundation No. 23-25-00417 (https://rscf.ru/project/23-25-00417/).</funding-statement><funding-statement xml:lang="ru">Данная работа финансировалась за счет средств РНФ № 23-25-00417 (https://rscf.ru/project/23-25-00417/).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Maggini S, Pierre A, Calder PC (2018) Immune Function and Micronutrient Requirements Change over the Life Course. Nutrients 10(10). https://doi.org/10.3390/nu10101531</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zhao M, Tuo H, Wang S, Zhao L (2020) The Effects of Dietary Nutrition on Sleep and Sleep Disorders. Mediat Inflamm 2020: 3142874. https://doi.org/10.1155/2020/3142874</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Adamovich Y, Aviram R, Asher G (2015) The emerging roles of lipids in circadian control. Biochim Biophys Acta 1851(8): 1017–1025. https://doi.org/10.1016/j.bbalip.2014.11.013</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ko CW, Qu J, Black DD, Tso P (2020) Regulation of intestinal lipid metabolism: current concepts and relevance to disease. Nat Rev Gastroenterol Hepatol 17(3): 169–183. https://doi.org/10.1038/s41575-019-0250-7</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shi J, Fan J, Su Q, Yang Z (2019) Cytokines and Abnormal Glucose and Lipid Metabolism. Front Endocrinol (Lausanne) 10: 703. https://doi.org/10.3389/fendo.2019.00703</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hachem M, Ahmmed MK, Nacir-Delord H (2023) Phospholipidomics in Clinical Trials for Brain Disorders: Advancing our Understanding and Therapeutic Potentials. Mol Neurobiol. https://doi.org/10.1007/s12035-023-03793-y</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ma X, Li X, Wang W, Zhang M, Yang B, Miao Z (2022) Phosphatidylserine, inflammation, and central nervous system diseases. Front Aging Neurosci 14: 975176. https://doi.org/10.3389/fnagi.2022.975176</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1(1): 31–39. https://doi.org/10.1038/35036052</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Chakraborty M, Jiang XC (2013) Sphingomyelin and its role in cellular signaling. Adv Exp Med Biol 991: 1–14. https://doi.org/10.1007/978-94-007-6331-9_1</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ruysschaert JM, Lonez C (2015) Role of lipid microdomains in TLR-mediated signalling. Biochim Biophys Acta 1848(9): 1860–1867. https://doi.org/10.1016/j.bbamem.2015.03.014</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Estes RE, Lin B, Khera A, Davis MY (2021) Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo? Front Mol Neurosci 14: 788695. https://doi.org/10.3389/fnmol.2021.788695</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Hamilton LK, Fernandes KJL (2018) Neural stem cells and adult brain fatty acid metabolism: Lessons from the 3xTg model of Alzheimer’s disease. Biol Cell 110(1): 6–25. https://doi.org/10.1111/boc.201700037</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Tamura Y, Yamato M, Kataoka Y (2022) Animal Models for Neuroinflammation and Potential Treatment Methods. Front Neurol 13: 890217. https://doi.org/10.3389/fneur.2022.890217</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS (2021) Cardiolipin, Mitochondria, and Neurological Disease. Trends Endocrinol Metab 32(4): 224–237. https://doi.org/10.1016/j.tem.2021.01.006</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Aufschnaiter A, Kohler V, Diessl J, Peselj C, Carmona-Gutierrez D, Keller W, Buttner S (2017) Mitochondrial lipids in neurodegeneration. Cell Tissue Res 367(1): 125–140. https://doi.org/10.1007/s00441-016-2463-1</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN (2021) Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 22(21). https://doi.org/10.3390/ijms222111682</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Petan T, Mancek-Keber M (2022) Half is enough: Oxidized lysophospholipids as novel bioactive molecules. Free Radic Biol Med 188: 351–362. https://doi.org/10.1016/j.freeradbiomed.2022.06.228</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Borisova MA, Snytnikova OA, Litvinova EA, Achasova KM, Babochkina TI, Pindyurin AV, Tsentalovich YP, Kozhevnikova EN (2020) Fucose Ameliorates Tryptophan Metabolism and Behavioral Abnormalities in a Mouse Model of Chronic Colitis. Nutrients 12(2). https://doi.org/10.3390/nu12020445</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Morozova MV, Borisova MA, Snytnikova OA, Achasova KM, Litvinova EA, Tsentalovich YP, Kozhevnikova EN (2022) Colitis-associated intestinal microbiota regulates brain glycine and host behavior in mice. Sci Rep 12(1): 16345. https://doi.org/10.1038/s41598-022-19219-z</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Borisova MA, Achasova KM, Morozova KN, Andreyeva EN, Litvinova EA, Ogienko AA, Morozova MV, Berkaeva MB, Kiseleva E, Kozhevnikova EN (2020) Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epithelium. Sci Rep 10(1): 21135. https://doi.org/10.1038/s41598-020-78141-4</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Roy R, Paul R, Bhattacharya P, Borah A (2023) Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology. ACS Chem Neurosci 14(16): 2830–2848. https://doi.org/10.1021/acschemneuro.3c00070</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Graham DB, Xavier RJ (2020) Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 578(7796): 527–539. https://doi.org/10.1038/s41586-020-2025-2</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Geyer MA, Dulawa SC (2003) Assessment of murine startle reactivity, prepulse inhibition, and habituation. Curr Protoc Neurosci Chapter 8: Unit 8 17. https://doi.org/10.1002/0471142301.ns0817s24</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Cadenhead KS, Geyer MA, Braff DL (1993) Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150(12): 1862–1867. https://doi.org/10.1176/ajp.150.12.1862</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wolff AR, Bilkey DK (2010) The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 213(2): 323–327. https://doi.org/10.1016/j.bbr.2010.05.008</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47(2): 181–188. https://doi.org/10.1001/archpsyc.1990.01810140081011</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Белоусова ИИ, Гладких ДВ, Железова АИ, Стефанова НА, Колосова НГ, Амстиславская ТГ (2009) Возрастные аспекты репродуктивной функции самцов крыс с обычным и ускоренным темпом старения. Рос физиол журн им ИМ Сеченова 95(11): 1258–1267. [Belousova II, Gladkich DV, Ghelezova AI, Stephanova NA, Kolosova NG, Amstislavskaya TG (2009) Age Aspeccts of Neurohormonal and Neurochemical Regulation of Sexual Behavior in Male Rats. Russ J Physiol 95(11): 1258–1267. (In Russ)].</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Michalikova S, van Rensburg R, Chazot PL, Ennaceur A (2010) Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test. Behav Brain Res 207(2): 402–417. https://doi.org/10.1016/j.bbr.2009.10.028</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Новиков СН (1988) Феромоны и размножение млекопитающих: физиол. аспекты. Наука. Ленингр отд-ние. [Novikov SN (1988) Pheromones and reproduction in mammals. Nauka. (LO). 1988. (In Russ)].</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Amstislavskaya TG, Bulygina VV, Tikhonova MA, Maslova LN (2013) Social isolation during peri-adolescence or adulthood: effects on sexual motivation, testosterone and corticosterone response under conditions of sexual arousal in male rats. Chin J Physiol 56(1): 36–43. https://doi.org/10.4077/CJP.2013.BAA074</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Zolotykh MA, Kozhevnikova EN (2017) The effect of social experience on olfactory preference in male mice. Appl Animal Behav Sci 189: 85–90. https://doi.org/10.1016/j.applanim.2017.01.013</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Joel D (2006) Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry 30(3): 374–388. https://doi.org/10.1016/j.pnpbp.2005.11.006</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Takahashi H, Komatsu S, Nakahachi T, Ogino K, Kamio Y (2016) Relationship of the Acoustic Startle Response and Its Modulation to Emotional and Behavioral Problems in Typical Development Children and Those with Autism Spectrum Disorders. J Autism Dev Disord 46(2): 534–543. https://doi.org/10.1007/s10803-015-2593-4</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Berding K, Vlckova K, Marx W, Schellekens H, Stanton C, Clarke G, Jacka F, Dinan TG, Cryan JF (2021) Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health. Adv Nutr 12(4): 1239–1285. https://doi.org/10.1093/advances/nmaa181</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Hamamah S, Amin A, Al-Kassir AL, Chuang J, Covasa M (2023) Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake. Nutrients 15(15). https://doi.org/10.3390/nu15153365</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Agagunduz D, Icer MA, Yesildemir O, Kocak T, Kocyigit E, Capasso R (2023) The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus. J Transl Med 21(1): 240. https://doi.org/10.1186/s12967-023-04088-5</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Pifferi F, Laurent B, Plourde M (2021) Lipid Transport and Metabolism at the Blood-Brain Interface: Implications in Health and Disease. Front Physiol 12: 645646. https://doi.org/10.3389/fphys.2021.645646</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Santos AL, Preta G (2018) Lipids in the cell: organisation regulates function. Cell Mol Life Sci 75(11): 1909–1927. https://doi.org/10.1007/s00018-018-2765-4</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Lowry TW, Kusi-Appiah AE, Fadool DA, Lenhert S (2023) Odor Discrimination by Lipid Membranes. Membranes (Basel) 13(2). https://doi.org/10.3390/membranes13020151</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL (2017) The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr 1859(9 Pt B): 1558–1572. https://doi.org/10.1016/j.bbamem.2017.04.006</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Dennis EA (2015) Introduction to Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease. J Lipid Res 56(7): 1245–1247. https://doi.org/10.1194/jlr.E061101</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Johnson AA, Stolzing A (2019) The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell 18(6): e13048. https://doi.org/10.1111/acel.13048</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Farooqui AA, Horrocks LA (2005) Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod Nutr Dev 45(5): 613–631. https://doi.org/10.1051/rnd:2005049</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Nelson RK, Frohman MA (2015) Physiological and pathophysiological roles for phospholipase D. J Lipid Res 56(12): 2229–2237. https://doi.org/10.1194/jlr.R059220</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Salvi F, Gadda G (2013) Human choline dehydrogenase: medical promises and biochemical challenges. Arch Biochem Biophys 537(2): 243–252. https://doi.org/10.1016/j.abb.2013.07.018</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Leventis PA, Grinstein S (2010) The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39: 407–427. https://doi.org/10.1146/annurev.biophys.093008.131234</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Das P, Estephan R, Banerjee P (2003) Apoptosis is associated with an inhibition of aminophospholipid translocase (APTL) in CNS-derived HN2-5 and HOG cells and phosphatidylserine is a recognition molecule in microglial uptake of the apoptotic HN2-5 cells. Life Sci 72(23): 2617–2627. https://doi.org/10.1016/s0024-3205(03)00163-2</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Kay JG, Fairn GD (2019) Distribution, dynamics and functional roles of phosphatidylserine within the cell. Cell Commun Signal 17(1): 126. https://doi.org/10.1186/s12964-019-0438-z</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Lenoir G, D’Ambrosio JM, Dieudonne T, Copic A (2021) Transport Pathways That Contribute to the Cellular Distribution of Phosphatidylserine. Front Cell Dev Biol 9: 737907. https://doi.org/10.3389/fcell.2021.737907</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Kim HY, Akbar M, Kim YS (2010) Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostagland Leukot Essent Fatty Acids 82(4-6): 165–172. https://doi.org/10.1016/j.plefa.2010.02.025</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>More MI, Freitas U, Rutenberg D (2014) Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer’s disease and dementia. Adv Ther 31(12): 1247–1262. https://doi.org/10.1007/s12325-014-0165-1</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Bond P (2017) Phosphatidic acid: biosynthesis, pharmacokinetics, mechanisms of action and effect on strength and body composition in resistance-trained individuals. Nutr Metab (Lond) 14: 12. https://doi.org/10.1186/s12986-017-0166-6</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Zegarlinska J, Piascik M, Sikorski AF, Czogalla A (2018) Phosphatidic acid - a simple phospholipid with multiple faces. Acta Biochim Pol 65(2): 163–171. https://doi.org/10.18388/abp.2018_2592</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Pages C, Simon MF, Valet P, Saulnier-Blache JS (2001) Lysophosphatidic acid synthesis and release. Prostagland Other Lipid Mediat 64(1–4): 1–10. https://doi.org/10.1016/s0090-6980(01)00110-1</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Moolenaar WH (1995) Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270(22): 12949–12952. https://doi.org/10.1074/jbc.270.22.12949</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Hines OJ, Ryder N, Chu J, McFadden D (2000) Lysophosphatidic acid stimulates intestinal restitution via cytoskeletal activation and remodeling. J Surg Res 92(1): 23–28. https://doi.org/10.1006/jsre.2000.5941</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Jedrzejewska-Szmek J, Dorman DB, Blackwell KT (2023) Making time and space for calcium control of neuron activity. Curr Opin Neurobiol 83: 102804. https://doi.org/10.1016/j.conb.2023.102804</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Parato J, Bartolini F (2021) The microtubule cytoskeleton at the synapse. Neurosci Lett 753: 135850. https://doi.org/10.1016/j.neulet.2021.135850</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Rojas-Charry L, Nardi L, Methner A, Schmeisser MJ (2021) Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders. J Mol Med (Berl) 99(2): 161–178. https://doi.org/10.1007/s00109-020-02018-2</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Pozo Devoto VM, Onyango IG, Stokin GB (2022) Mitochondrial behavior when things go wrong in the axon. Front Cell Neurosci 16: 959598. https://doi.org/10.3389/fncel.2022.959598</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Licht-Mayer S, Campbell GR, Canizares M, Mehta AR, Gane AB, McGill K, Ghosh A, Fullerton A, Menezes N, Dean J, Dunham J, Al-Azki S, Pryce G, Zandee S, Zhao C, Kipp M, Smith KJ, Baker D, Altmann D, Anderton SM, Kap YS, Laman JD, Hart BA, Rodriguez M, Watzlawick R, Schwab JM, Carter R, Morton N, Zagnoni M, Franklin RJM, Mitchell R, Fleetwood-Walker S, Lyons DA, Chandran S, Lassmann H, Trapp BD, Mahad DJ (2020) Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis. Acta Neuropathol 140(2): 143–167. https://doi.org/10.1007/s00401-020-02179-x</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Khan MM, Paez HG, Pitzer CR, Alway SE (2023) The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders. Curr Neuropharmacol 21(5): 1100–1116. https://doi.org/10.2174/1570159X05666220908100545</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Saydakova S, Morozova K, Snytnikova O, Morozova M, Boldyreva L, Kiseleva E, Tsentalovich Y, Kozhevnikova E (2023) The Effect of Dietary Phospholipids on the Ultrastructure and Function of Intestinal Epithelial Cells. Int J Mol Sci 24(2). https://doi.org/10.3390/ijms24021788</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Mayr JA (2015) Lipid metabolism in mitochondrial membranes. J Inherit Metab Dis 38(1): 137–144. https://doi.org/10.1007/s10545-014-9748-x</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Funai K, Summers SA, Rutter J (2020) Reign in the membrane: How common lipids govern mitochondrial function. Curr Opin Cell Biol 63: 162–173. https://doi.org/10.1016/j.ceb.2020.01.006</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Bathina S, Das UN (2023) Role of Mitochondrial Dysfunction in Cellular Lipid Homeostasis and Disease. Discov Med 35(178): 653–663. https://doi.org/10.24976/Discov.Med.202335178.64</mixed-citation></ref></ref-list></back></article>
